The global intravascular stents market is anticipated to grow at a CAGR of 9.4% during the forecast period (2023-2030). The key factors for the promising growth of market includes the increasing number of patients undergoing stroke, technological advancements, enhancement in health facilities, rising healthcare investments, growing requirement for minimally invasive surgery procedures and increasing change in lifestyle related diseases such as obesity which is the major cause of increasing stroke incidences. According to the World Stroke Organization 2022, there are 12.2 million new strokes per year one every 3 seconds around the globe. There are 101 million people around the globe are living with stroke aftermath. this number has almost doubled over the last 30 years. Further, 1 in 4 people will have a stroke in their lifetime this number has increased 50%over the last 17 years. Up to 80% of strokes and heart attacks happen in people with 63% low or moderate CVD absolute risk. In 2019, 63% of stroke happened in people younger than 70 years old.
Browse the full report description of “Intravascular Stents Market Size, Share & Trends Analysis Report by Product (Coronary Stents, Neurovascular Stents, Peripheral Stents, Renal Artery Stents, and Aortic Stents), by Mode of Delivery (Self-Expanding Stents and Balloon-Expandable Stents), by End-User (Hospitals and Cardiac Centers and Ambulatory Surgical Centers), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/intravascular-stents-market
Moreover, the growing cases of cerebral aneurysms and brain aneurysms in various nations across the globe have led to increased use of carotid artery stents and it has generated maximum revenue in recent times. Some of the key participating global neurovascular stent retrievers’ market are Nitinol Devices & Components, Inc., Stryker Corp., Medtronic Plc, STI Laser Industries, Ltd., Norman Noble, INC., Hobbs Medical IN, Akron Inc. Advent Devices Pvt. Ltd, Meril Life Science Pvt. Ltd. The manufacturers are focusing on investing in R&D activities and new launches to bring new technologies to reduce stroke problems. For instance, in June 2023, Fluid Biomed Inc., a medical device company developing ReSolv™, the world's first hybrid polymer-metal flow-diverting stent to treat brain aneurysms, launched the REDIRECT, its first-in-human clinical trial. The complications and the risk associated with the use of neurovascular stents are largely reduced due to the use of newly launched products and innovative products in the market.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Mode of Delivery
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes B. Braun SE, Medtronic plc, Terumo Corp., Stryker Corp., Abbott Laboratories, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Intravascular Stents Market Report Segment
By Product
By Mode of Delivery
By End-User
Global Intravascular Stents Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/intravascular-stents-market